These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2840110)

  • 1. Determination of pyrimidine 5'-nucleotidase (P5N) activity in whole blood as an index of lead exposure.
    Sakai T; Araki T; Ushio K
    Br J Ind Med; 1988 Jun; 45(6):420-5. PubMed ID: 2840110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.
    Cook LR; Angle CR; Stohs SJ
    Br J Ind Med; 1986 Jun; 43(6):387-90. PubMed ID: 3013277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between inhibition of erythrocyte pyrimidine 5'-nucleotidase activity and biological response for porphyrin metabolism in workers occupationally exposed to lead.
    Tomokuni K; Ichiba M; Hirai Y; Hasegawa T; Sugimoto K
    Int Arch Occup Environ Health; 1988; 60(6):431-6. PubMed ID: 2842263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simplified method for determining erythrocyte pyrimidine 5'-nucleotidase (P5N) activity by HPLC and its value in monitoring lead exposure.
    Sakai T; Ushio K
    Br J Ind Med; 1986 Dec; 43(12):839-44. PubMed ID: 3026435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of blood lead by HPLC assay of erythrocyte pyrimidine 5'-nucleotidase.
    Cook LR; Angle CR; Kubitschek CE; Stohs SJ
    J Anal Toxicol; 1987; 11(1):39-42. PubMed ID: 3029506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte pyrimidine 5'-nucleotidase activity in workers exposed to lead, mercury or cadmium.
    Mohammed-Brahim B; Buchet JP; Lauwerys R
    Int Arch Occup Environ Health; 1985; 55(3):247-52. PubMed ID: 2987134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on erythrocyte pyrimidine 5'-nucleotidase (P5N) test and its evaluation in workers occupationally exposed to lead.
    Ichiba M; Tomokuni K
    Int Arch Occup Environ Health; 1990; 62(4):305-10. PubMed ID: 2379961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between activity of erythrocyte pyrimidine 5'-nucleotidase (P5N) and concentration of magnesium or zinc in blood in workers exposed to lead].
    Ichiba M; Tomokuni K
    Sangyo Igaku; 1988 Sep; 30(5):408-9. PubMed ID: 2849695
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of lead exposure in workers at a lead-acid battery factory in Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Kim Y; Harada K; Ohmori S; Lee BK; Miura H; Ueda A
    Occup Environ Med; 1995 Jul; 52(7):484-8. PubMed ID: 7670624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrimidine nucleoside monophosphate kinase hyperactivity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA; Zerez CR; Tanaka KR
    Br J Haematol; 1987 May; 66(1):91-6. PubMed ID: 3036196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of erythrocyte pyrimidine 5'-nucleotidase (P5N) activity in workers exposed to lead.
    Ichiba M; Tomokuni K
    Br J Ind Med; 1988 Oct; 45(10):718-9. PubMed ID: 2848571
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythrocyte pyrimidine 5'-nucleotidase and deoxynucleotidase isozymes: metallosensitivity and kinetics.
    Cook L; Kubitschek C; Stohs S; Angle C
    Drug Chem Toxicol; 1988 Jun; 11(2):195-213. PubMed ID: 2841083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte pyrimidine 5'-nucleotidase inhibition by acute lead exposure in neonatal rats.
    Konantakieti C; Beuthin FC; Louis-Ferdinand RT
    J Biochem Toxicol; 1986 Sep; 1(3):51-9. PubMed ID: 2856073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPLC analysis of erythrocyte pyrimidine-5'-nucleotidase inhibition by lead.
    Rocco RM; Smart JL; Brown DR; Blumberg JB
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):127-36. PubMed ID: 6273981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of activity of erythrocyte pyrimidine 5'-nucleotidase (P5N) in lead exposed workers: with focus on the effect on hemoglobin.
    Kim Y; Yoo CI; Lee CR; Lee JH; Lee H; Kim SR; Chang SH; Lee WJ; Hwang CH; Lee YH
    Ind Health; 2002 Jan; 40(1):23-7. PubMed ID: 11926511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low level lead and inhibition of erythrocyte pyrimidine nucleotidase.
    Angle CR; McIntire MS
    Environ Res; 1978 Oct; 17(2):296-302. PubMed ID: 233817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced activity of pyrimidine 5'-nucleotidase in rat red blood cells during erythropoiesis.
    Hokari S; Miyazaki T; Hasegawa M; Komoda T
    Biol Chem; 1998 Mar; 379(3):329-33. PubMed ID: 9563829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatographic analysis of human erythrocyte pyrimidine 5'-nucleotidase from five patients with pyrimidine 5'-nucleotidase deficiency.
    Hirono A; Fujii H; Natori H; Kurokawa I; Miwa S
    Br J Haematol; 1987 Jan; 65(1):35-41. PubMed ID: 3028466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of inhibition of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinic acid dehydratase by lead.
    Tomokuni K; Ichiba M
    Toxicol Lett; 1988 Feb; 40(2):159-63. PubMed ID: 2829393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isozymes of human erythrocyte pyrimidine 5'-nucleotidase--chromatographic separation and their properties.
    Hirono A; Fujii H; Miwa S
    Jpn J Exp Med; 1985 Feb; 55(1):37-44. PubMed ID: 2993713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.